2410423-31-1

2410423-31-1 structure

Name: IKKβ-IN-1
Chemical Name: IKKβ-IN-1
CAS Number: 2410423-31-1
Molecular Formula: C₃₁H₃₀N₄O₄S
Molecular Weight: 554.66
Catalog: Signaling Pathways NF-κB IKK
Create Date: 2022-05-31 12:19:27
Modify Date: 2024-09-12 08:54:50
IKKβ-IN-1 is a potent and orally active IkappaB (IKK-β) inhibitor with IC50 of 0.20 μM. IKKβ-IN-1 can reduce PGE2 and TNF-α production in mouse macrophage cells. IKKβ-IN-1 has the ability to protect mice against septic shock induced mortality[1].

Name	IKKβ-IN-1

Description	IKKβ-IN-1 is a potent and orally active IkappaB (IKK-β) inhibitor with IC50 of 0.20 μM. IKKβ-IN-1 can reduce PGE2 and TNF-α production in mouse macrophage cells. IKKβ-IN-1 has the ability to protect mice against septic shock induced mortality[1].
Related Catalog	Signaling Pathways >> NF-κB >> IKK Research Areas >> Inflammation/Immunology
Target	IKK-β:0.2 (IC50)
In Vitro	IKKβ-IN-1 (compound 7a) (0.1, 1 and 10 μM; 24 hours) does not show significant cytotoxicity at the tested three concentrations[1]. IKKβ-IN-1 (0.1, 1 and 10 μM; 1 hours) significantly reduces PGE2 production even at the low 0.1 μM concentration, and IC50 is 9.83 μM[1]. IKKβ-IN-1 (0.1, 1 and 10 μM; 1 hours) elicits 44% reduction of TNF-α production at 10 μM concentration, and IC50 is 6.27 μM[1]. Cell Viability Assay Cell Line: RAW 264.7 macrophage cells[1] Concentration: 0.1, 1 and 10 μM Incubation Time: 24 hours Result: Did not show significant cytotoxicity at the tested three concentrations.
In Vivo	IKKβ-IN-1 (5 or 50 mg/kg; PO, single) exhibits an efficient protection of LPS-induced production of the inflammatory mediators at both of the two administered doses[1]. Animal Model: C57BL/6 male mice (6 or 10 weeks; LPS-induced production of the inflammatory mediators)[1] Dosage: 5 or 50 mg/kg Administration: PO, single (1 hour before LPS injection; survival was monitored for 36 hours) Result: Exhibited an efficient protection of LPS-induced production of the inflammatory mediators at both of the two administered doses.
References	[1]. Elkamhawy A, Kim NY, Hassan AHE, et al. Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents. Eur J Med Chem. 2020;188:111955.

Molecular Formula	C₃₁H₃₀N₄O₄S
Molecular Weight	554.66

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

2410423-31-1	2471981-21-0
407587-01-3	2366149-83-7
924296-18-4	877225-09-7
2055990-90-2	1207358-59-5
1364683-67-9	1998139-29-9
1016734-20-5	181472-55-9
161711-37-1	1016703-36-8
882041-34-1	80333-92-2
898461-10-4	99438-32-1
1016703-42-6	727359-82-2